Unknown

Dataset Information

0

Nitric oxide-mediated regulation of ?-amyloid clearance via alterations of MMP-9/TIMP-1.


ABSTRACT: Fibrillar amyloid plaques are largely composed of amyloid-beta (A?) peptides that are metabolized into products, including A?1-16, by proteases including matrix metalloproteinase 9 (MMP-9). The balance between production and degradation of A? proteins is critical to amyloid accumulation and resulting disease. Regulation of MMP-9 and its endogenous inhibitor tissue inhibitor of metalloproteinase (TIMP)-1 by nitric oxide (NO) has been shown. We hypothesize that nitric oxide synthase (NOS2) protects against Alzheimer's disease pathology by increasing amyloid clearance through NO regulation of MMP-9/TIMP-1 balance. We show NO-mediated increased MMP-9/TIMP-1 ratios enhanced the degradation of fibrillar A? in vitro, which was abolished when silenced for MMP-9 protein translation. The in vivo relationship between MMP-9, NO and A? degradation was examined by comparing an Alzheimer's disease mouse model that expresses NOS2 with a model lacking NOS2. To quantitate MMP-9 mediated changes, we generated an antibody recognizing the A?1-16 fragment, and used mass spectrometry multi-reaction monitoring assay for detection of immunoprecipitated A?1-16 peptides. A?1-16 levels decreased in brain lysates lacking NOS2 when compared with strains that express human amyloid precursor protein on the NOS2 background. TIMP-1 increased in the APPSwDI/NOS2(-/-) mice with decreased MMP activity and increased amyloid burden, thereby supporting roles for NO in the regulation of MMP/TIMP balance and plaque clearance.

SUBMITTER: Ridnour LA 

PROVIDER: S-EPMC3614913 | biostudies-literature | 2012 Dec

REPOSITORIES: biostudies-literature

altmetric image

Publications

Nitric oxide-mediated regulation of β-amyloid clearance via alterations of MMP-9/TIMP-1.

Ridnour Lisa A LA   Dhanapal Sneha S   Hoos Michael M   Wilson Joan J   Lee Jennifer J   Cheng Robert Y S RY   Brueggemann Ernst E EE   Hines Harry B HB   Wilcock Donna M DM   Vitek Michael P MP   Wink David A DA   Colton Carol A CA  

Journal of neurochemistry 20121025 5


Fibrillar amyloid plaques are largely composed of amyloid-beta (Aβ) peptides that are metabolized into products, including Aβ1-16, by proteases including matrix metalloproteinase 9 (MMP-9). The balance between production and degradation of Aβ proteins is critical to amyloid accumulation and resulting disease. Regulation of MMP-9 and its endogenous inhibitor tissue inhibitor of metalloproteinase (TIMP)-1 by nitric oxide (NO) has been shown. We hypothesize that nitric oxide synthase (NOS2) protect  ...[more]

Similar Datasets

| S-EPMC3434220 | biostudies-literature
| S-EPMC7370614 | biostudies-literature
| S-EPMC4502358 | biostudies-literature
| S-EPMC3402396 | biostudies-literature
| S-EPMC6103708 | biostudies-literature
| S-EPMC3001000 | biostudies-literature
| S-EPMC7955073 | biostudies-literature
| S-EPMC4323017 | biostudies-literature
| S-EPMC7531049 | biostudies-literature
| S-EPMC5865478 | biostudies-literature